Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human FADS2 ELISA Kit (AC3347)
Cat.#: ASET-1936
Specifications
Description Human FADS2 ELISA Kit allows for the in vitro quantitative determination of human FADS2 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 46.875 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 78.125-5000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1761 Human MAPK ELISA Kit (AC3172) Quantitative inquiry ASET-2352 Hamster Leptin ELISA Kit (AC3763) Quantitative inquiry ASET-1901 Mouse CRMP2 ELISA Kit (AC3312) Quantitative inquiry ASET-2082 Human LAMB3 ELISA Kit (AC3493) Quantitative inquiry ASET-1155 Human SOX9 ELISA Kit (AC2566) Quantitative inquiry ASET-2327 Human NRP2 ELISA Kit (AC3738) Quantitative inquiry ASET-1862 Mouse CPE ELISA Kit (AC3273) Quantitative inquiry ASET-1655 Rat GDNF ELISA Kit (AC3066) Quantitative inquiry ASET-1683 Human NOX3 ELISA Kit (AC3094) Quantitative inquiry ASET-1792 Human PGRPS ELISA Kit (AC3203) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket